humulin m3 kwikpen
eli lilly nederland b.v. - insulinas, žmogaus - injekcinė suspensija užpildytame švirkštiklyje - 100 tv/ml - insulin (human)
ibuprofen nvt
nvt, uab - ibuprofenas - minkštosios kapsulės - 400 mg - ibuprofen
tamsulosin stada
stada arzneimittel ag - tamsulozino hidrochloridas - modifikuoto atpalaidavimo kietosios kapsulės - 0,4 mg - tamsulosin
mirador® forte
adama - koncentruota emulsija - azoksistrobinas + tebukonazolas - fungicidai
mavrik®
adama - aliejinė vandens emulsija - tau–fluvalinatas - insekticidai
poleposition® ir mirador® mišinys
adama - koncentruota emulsija/koncentruota suspensija - azoksistrobinas + protiokonazolas - fungicidai
airexar spiromax
teva b.v. - salmeterol, fluticasone propionatas - pulmonary disease, chronic obstructive; asthma - vaistai nuo obstrukcinių kvėpavimo takų ligų, - airexar spiromax skirtas vartoti tik suaugusiesiems nuo 18 metų ir vyresnių. asthmaairexar spiromax is indicated for the regular treatment of patients with severe asthma where use of a combination product (inhaled corticosteroid and long-acting β2 agonist) is appropriate:- patients not adequately controlled on a lower strength corticosteroid combination productor- patients already controlled on a high dose inhaled corticosteroid and long-acting β2 agonist. lėtinė obstrukcinė plaučių liga (lopl)airexar spiromax fluorouracilu ir simptominis gydymas pacientams, sergantiems lopl, su fev1.
biresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - vaistai nuo obstrukcinių kvėpavimo takų ligų, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
budesonide/formoterol teva pharma b.v.
teva pharma b.v. - budesonide, formoterol - astma - vaistai nuo obstrukcinių kvėpavimo takų ligų, - budesonide/formoterol teva pharma b. skiriamas tik suaugusiems, 18 metų ir vyresniems. asthmabudesonide/formoterol teva pharma b. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate: orin patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists. in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.